• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Cardiovascular complications of chronic rheumatic diseases, An Issue of Rheumatic Disease Clinics of North America

Cardiovascular complications of chronic rheumatic diseases, An Issue of Rheumatic Disease Clinics of North America

9780323849289
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
595,29 zł
506,00 zł Zniżka 89,29 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 506,00 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
In this issue of Rheumatic Disease Clinics, guest editors Drs. M. Elaine Husni? and George A. Karpouzas bring their considerable expertise to the topic of Cardiovascular Complications of Chronic Rheumatic Diseases. Top experts in the field cover key topics such as primary and secondary atherosclerotic cardiovascular (ASCVD) risk prevention in the rheumatic disease, pro-thrombotic and pro-atherogenic anti-phospholipid antibodies, recommendations for the use of NSAIDs and CVD risk, and more.
Szczegóły produktu
Elsevier
93885
9780323849289
9780323849289

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
450
  • Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis
    Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach
    Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
    Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
    Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
    Venous Thromboembolism in the Inflammatory Rheumatic Diseases
    Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
    Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
    Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
    Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
Komentarze (0)